With the Maynepharma takeover deal gaining approval from US authorities overnight Symbion (division of Mayne) can now put forward a deal.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025